Stifel Nicolaus Boosts Envista (NYSE:NVST) Price Target to $27.00

Envista (NYSE:NVST) had its price target increased by research analysts at Stifel Nicolaus from $25.00 to $27.00 in a research report issued to clients and investors on Wednesday, Marketbeat.com reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective suggests a potential upside of 8.84% from the stock’s current price.

NVST has been the subject of a number of other reports. Barclays began coverage on shares of Envista in a report on Monday, December 8th. They set an “overweight” rating and a $24.00 target price for the company. Weiss Ratings restated a “sell (d)” rating on shares of Envista in a report on Monday, December 29th. Evercore ISI reaffirmed an “outperform” rating on shares of Envista in a research report on Friday, October 31st. UBS Group increased their price target on Envista from $22.00 to $25.00 and gave the company a “neutral” rating in a research report on Tuesday. Finally, Wall Street Zen upgraded Envista from a “buy” rating to a “strong-buy” rating in a report on Monday, January 26th. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $22.75.

Envista Trading Up 4.8%

Shares of NVST stock opened at $24.81 on Wednesday. The stock has a 50-day simple moving average of $22.63 and a 200 day simple moving average of $21.16. The stock has a market capitalization of $4.08 billion, a P/E ratio of 275.66, a P/E/G ratio of 1.05 and a beta of 1.01. Envista has a fifty-two week low of $14.22 and a fifty-two week high of $25.41. The company has a quick ratio of 2.02, a current ratio of 2.37 and a debt-to-equity ratio of 0.47.

Envista (NYSE:NVST) last issued its quarterly earnings results on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.32 by $0.06. The company had revenue of $750.60 million during the quarter, compared to the consensus estimate of $680.26 million. Envista had a net margin of 0.58% and a return on equity of 5.90%. Envista’s revenue was up 15.0% on a year-over-year basis. During the same period in the prior year, the company earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, sell-side analysts expect that Envista will post 1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Envista

A number of institutional investors have recently bought and sold shares of the business. Farther Finance Advisors LLC increased its holdings in shares of Envista by 317.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after purchasing an additional 1,026 shares during the period. Caitong International Asset Management Co. Ltd grew its position in Envista by 16,711.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after purchasing an additional 1,504 shares in the last quarter. Allworth Financial LP increased its stake in Envista by 75.4% in the 4th quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after buying an additional 776 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Envista by 73.1% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock worth $44,000 after buying an additional 949 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its stake in shares of Envista by 378.0% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock valued at $47,000 after buying an additional 1,909 shares during the period.

Trending Headlines about Envista

Here are the key news stories impacting Envista this week:

• Positive Sentiment: Q4 earnings beat and solid quarter — Envista reported $0.38 EPS vs. $0.32 consensus and showed revenue/operating progress for the quarter, prompting the market uplift. Envista Reports Fourth Quarter 2025 Results
• Positive Sentiment: Management issued stronger FY‑2026 guidance — Envista raised its EPS outlook to $1.350–$1.450, above Street expectations, which materially improves forward earnings visibility and is a key reason investors are buying the stock. Envista Holdings soars after beating Q4 estimates, issues strong guidance
• Positive Sentiment: Analyst lift — Stifel raised its price target to $27 with a Buy rating, adding upward pressure by signaling upside to the current stock level. Envista price target raised by Stifel
• Neutral Sentiment: Coverage & screeners highlight value traits — Zacks flagged Envista as a top-ranked value stock, which may attract value-oriented buyers but doesn’t directly change fundamentals. Envista is a Top-Ranked Value Stock
• Negative Sentiment: Valuation and margin context — despite the beat, Envista trades at a high reported PE (~275x trailing) and showed a thin net margin (~0.6%), leaving the name exposed if growth slips or if investors re-rate multiples; this is a risk to monitor even as near‑term sentiment is positive.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.